Pharmacology Exam Questions and Answers with Rationales 2026/2027 | Nursing
Pharmacology Exam Prep & Study Guide | Pharmacokinetics, Pharmacodynamics,
Medication Safety, Cardiovascular Drugs, Antibiotics, Endocrine Medications, CNS
Drugs, Pain Management & Drug Interactions | Practice Questions with Detailed
Rationales
Question 1: A 68-year-old male with a history of heart failure with reduced ejection fraction
(HFrEF) is started on a new medication that has been shown to reduce both preload and
afterload. Which of the following medication classes directly inhibits the conversion of
angiotensin I to angiotensin II, leading to these hemodynamic effects?
A. Beta-blockers
B. Direct renin inhibitors
C. Angiotensin-converting enzyme (ACE) inhibitors
D. Aldosterone antagonists
CORRECT ANSWER: C. Angiotensin-converting enzyme (ACE) inhibitors
Rationale: ACE inhibitors block the enzyme responsible for converting angiotensin I to
angiotensin II, a potent vasoconstrictor. This leads to a decrease in systemic vascular resistance
(afterload) and a reduction in aldosterone secretion, which decreases sodium and water
retention, thereby reducing preload. Beta-blockers primarily reduce heart rate and contractility.
Direct renin inhibitors block the conversion of angiotensinogen to angiotensin I. Aldosterone
antagonists block the effects of aldosterone at the receptor level.
Question 2: A patient is prescribed a drug that acts as a competitive antagonist at the
muscarinic acetylcholine receptors. Which of the following physiological effects would most
likely be observed as a result of this drug's action?
A. Miosis (pupillary constriction)
B. Bradycardia
C. Increased gastrointestinal motility
D. Bronchodilation
CORRECT ANSWER: D. Bronchodilation
Rationale: Muscarinic receptor antagonists, such as atropine, block the parasympathetic effects
mediated by acetylcholine. In the respiratory system, this leads to bronchodilation, as the
parasympathetic system normally causes bronchoconstriction. Miosis, bradycardia, and
increased gastrointestinal motility are all effects of muscarinic receptor activation, not
blockade.
Question 3: A 55-year-old patient with type 2 diabetes mellitus is started on metformin. The
physician explains that this drug primarily works by reducing hepatic glucose production.
Which of the following best describes the primary mechanism of action of metformin?
,A. Increasing insulin secretion from pancreatic beta cells
B. Decreasing gluconeogenesis in the liver and increasing peripheral glucose uptake
C. Slowing the absorption of carbohydrates from the gastrointestinal tract
D. Acting as a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist
CORRECT ANSWER: B. Decreasing gluconeogenesis in the liver and increasing peripheral
glucose uptake
Rationale: Metformin's primary mechanism involves activation of AMP-activated protein kinase
(AMPK), which leads to a reduction in hepatic gluconeogenesis and an increase in insulin
sensitivity in peripheral tissues, promoting glucose uptake. Sulfonylureas increase insulin
secretion. Alpha-glucosidase inhibitors slow carbohydrate absorption. Thiazolidinediones (e.g.,
pioglitazone) are PPAR-γ agonists.
Question 4: A patient is receiving a continuous intravenous infusion of a drug that follows
first-order elimination kinetics. If the infusion rate is doubled, what will happen to the
steady-state plasma concentration (Css)?
A. It will decrease by half.
B. It will remain the same.
C. It will double.
D. It will quadruple.
CORRECT ANSWER: C. It will double.
Rationale: For a drug administered by continuous intravenous infusion at a constant rate (k0),
the steady-state concentration (Css) is directly proportional to the infusion rate, as described by
the equation Css = k0 / (Cl), where Cl is clearance. Therefore, if the infusion rate (k0) is doubled
and clearance remains constant, the Css will also double.
Question 5: A 42-year-old woman is prescribed a selective serotonin reuptake inhibitor (SSRI)
for major depressive disorder. Which of the following adverse effects is most commonly
associated with this class of medications?
A. Hepatotoxicity
B. Sexual dysfunction
C. Hypertensive crisis
D. Agranulocytosis
CORRECT ANSWER: B. Sexual dysfunction
Rationale: SSRIs, such as fluoxetine and sertraline, are commonly associated with sexual
dysfunction, including decreased libido, erectile dysfunction, and anorgasmia. This is a frequent
reason for medication discontinuation. Hypertensive crisis is more characteristic of monoamine
oxidase inhibitors (MAOIs) when combined with tyramine-rich foods. Agranulocytosis and
hepatotoxicity are less common or associated with other drug classes.
,Question 6: A 70-year-old male with chronic kidney disease is given a new medication that is
primarily excreted renally. Which of the following pharmacokinetic parameters would be
most important to adjust in this patient to prevent drug toxicity?
A. Bioavailability (F)
B. Volume of distribution (Vd)
C. Half-life (t½)
D. Protein binding
CORRECT ANSWER: C. Half-life (t½)
Rationale: In renal impairment, the clearance of renally excreted drugs is reduced, leading to a
prolonged half-life (t½) and drug accumulation. Dose adjustments are typically based on the
extended half-life to maintain therapeutic levels and avoid toxicity. While volume of
distribution and protein binding can be affected by renal disease, the half-life is the primary
parameter used for dosing interval adjustments.
Question 7: A patient on warfarin therapy is prescribed amiodarone for atrial fibrillation. The
physician is concerned about a drug interaction. What is the most likely mechanism of this
interaction?
A. Displacement of warfarin from plasma protein binding sites
B. Inhibition of warfarin metabolism by CYP2C9
C. Induction of warfarin metabolism by CYP3A4
D. Additive antiplatelet effects
CORRECT ANSWER: B. Inhibition of warfarin metabolism by CYP2C9
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme responsible for
metabolizing the more active S-enantiomer of warfarin. This inhibition leads to increased
warfarin concentrations and a significantly elevated risk of bleeding. While amiodarone can also
interact with other pathways, CYP2C9 inhibition is the most significant mechanism.
Question 8: A 28-year-old woman with asthma is prescribed a long-acting beta-2 agonist
(LABA) as part of her maintenance therapy. Which of the following statements best describes
the recommended use of a LABA in asthma?
A. It should be used as monotherapy for mild intermittent asthma.
B. It is indicated for the acute relief of bronchospasm during an asthma attack.
C. It should always be used in combination with an inhaled corticosteroid (ICS).
D. It is the first-line treatment for exercise-induced bronchospasm.
CORRECT ANSWER: C. It should always be used in combination with an inhaled corticosteroid
(ICS).
, Rationale: LABAs (e.g., salmeterol, formoterol) are recommended for asthma management only
when used in combination with an ICS. Monotherapy with a LABA is associated with an
increased risk of asthma-related death due to masking of airway inflammation. They are not
used for acute relief (short-acting beta-2 agonists are used for that). While they can prevent
exercise-induced bronchospasm, they are not the first-line treatment for it.
Question 9: Which of the following bacterial cell wall synthesis inhibitors exerts its effect by
binding to the D-Ala-D-Ala terminal of the peptidoglycan precursor, thereby preventing
transpeptidase activity?
A. Gentamicin
B. Vancomycin
C. Ciprofloxacin
D. Erythromycin
CORRECT ANSWER: B. Vancomycin
Rationale: Vancomycin is a glycopeptide antibiotic that binds with high affinity to the D-Ala-D-
Ala terminus of the cell wall precursor unit. This prevents the transpeptidase (or penicillin-
binding proteins) from cross-linking the peptidoglycan strands, weakening the cell wall.
Gentamicin inhibits protein synthesis, ciprofloxacin inhibits DNA gyrase, and erythromycin
inhibits protein synthesis.
Question 10: A patient experiences a severe allergic reaction after receiving penicillin. The
physician decides to prescribe a macrolide antibiotic instead. Which of the following is the
primary mechanism of action of macrolides?
A. Inhibition of bacterial cell wall synthesis
B. Disruption of bacterial cell membrane function
C. Inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit
D. Inhibition of bacterial DNA replication by inhibiting DNA gyrase
CORRECT ANSWER: C. Inhibition of bacterial protein synthesis by binding to the 50S
ribosomal subunit
Rationale: Macrolides, such as erythromycin, clarithromycin, and azithromycin, are
bacteriostatic antibiotics that exert their action by reversibly binding to the 50S ribosomal
subunit, which inhibits peptide chain translocation and thus protein synthesis. They do not
affect cell wall synthesis, cell membrane, or DNA replication.
Question 11: A 60-year-old patient with benign prostatic hyperplasia (BPH) is prescribed
tamsulosin. Which of the following best describes the therapeutic effect of tamsulosin in this
condition?
A. It reduces the size of the prostate by inhibiting 5-alpha-reductase.
B. It relaxes the smooth muscle of the prostate and bladder neck to improve urine flow.
Pharmacology Exam Prep & Study Guide | Pharmacokinetics, Pharmacodynamics,
Medication Safety, Cardiovascular Drugs, Antibiotics, Endocrine Medications, CNS
Drugs, Pain Management & Drug Interactions | Practice Questions with Detailed
Rationales
Question 1: A 68-year-old male with a history of heart failure with reduced ejection fraction
(HFrEF) is started on a new medication that has been shown to reduce both preload and
afterload. Which of the following medication classes directly inhibits the conversion of
angiotensin I to angiotensin II, leading to these hemodynamic effects?
A. Beta-blockers
B. Direct renin inhibitors
C. Angiotensin-converting enzyme (ACE) inhibitors
D. Aldosterone antagonists
CORRECT ANSWER: C. Angiotensin-converting enzyme (ACE) inhibitors
Rationale: ACE inhibitors block the enzyme responsible for converting angiotensin I to
angiotensin II, a potent vasoconstrictor. This leads to a decrease in systemic vascular resistance
(afterload) and a reduction in aldosterone secretion, which decreases sodium and water
retention, thereby reducing preload. Beta-blockers primarily reduce heart rate and contractility.
Direct renin inhibitors block the conversion of angiotensinogen to angiotensin I. Aldosterone
antagonists block the effects of aldosterone at the receptor level.
Question 2: A patient is prescribed a drug that acts as a competitive antagonist at the
muscarinic acetylcholine receptors. Which of the following physiological effects would most
likely be observed as a result of this drug's action?
A. Miosis (pupillary constriction)
B. Bradycardia
C. Increased gastrointestinal motility
D. Bronchodilation
CORRECT ANSWER: D. Bronchodilation
Rationale: Muscarinic receptor antagonists, such as atropine, block the parasympathetic effects
mediated by acetylcholine. In the respiratory system, this leads to bronchodilation, as the
parasympathetic system normally causes bronchoconstriction. Miosis, bradycardia, and
increased gastrointestinal motility are all effects of muscarinic receptor activation, not
blockade.
Question 3: A 55-year-old patient with type 2 diabetes mellitus is started on metformin. The
physician explains that this drug primarily works by reducing hepatic glucose production.
Which of the following best describes the primary mechanism of action of metformin?
,A. Increasing insulin secretion from pancreatic beta cells
B. Decreasing gluconeogenesis in the liver and increasing peripheral glucose uptake
C. Slowing the absorption of carbohydrates from the gastrointestinal tract
D. Acting as a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist
CORRECT ANSWER: B. Decreasing gluconeogenesis in the liver and increasing peripheral
glucose uptake
Rationale: Metformin's primary mechanism involves activation of AMP-activated protein kinase
(AMPK), which leads to a reduction in hepatic gluconeogenesis and an increase in insulin
sensitivity in peripheral tissues, promoting glucose uptake. Sulfonylureas increase insulin
secretion. Alpha-glucosidase inhibitors slow carbohydrate absorption. Thiazolidinediones (e.g.,
pioglitazone) are PPAR-γ agonists.
Question 4: A patient is receiving a continuous intravenous infusion of a drug that follows
first-order elimination kinetics. If the infusion rate is doubled, what will happen to the
steady-state plasma concentration (Css)?
A. It will decrease by half.
B. It will remain the same.
C. It will double.
D. It will quadruple.
CORRECT ANSWER: C. It will double.
Rationale: For a drug administered by continuous intravenous infusion at a constant rate (k0),
the steady-state concentration (Css) is directly proportional to the infusion rate, as described by
the equation Css = k0 / (Cl), where Cl is clearance. Therefore, if the infusion rate (k0) is doubled
and clearance remains constant, the Css will also double.
Question 5: A 42-year-old woman is prescribed a selective serotonin reuptake inhibitor (SSRI)
for major depressive disorder. Which of the following adverse effects is most commonly
associated with this class of medications?
A. Hepatotoxicity
B. Sexual dysfunction
C. Hypertensive crisis
D. Agranulocytosis
CORRECT ANSWER: B. Sexual dysfunction
Rationale: SSRIs, such as fluoxetine and sertraline, are commonly associated with sexual
dysfunction, including decreased libido, erectile dysfunction, and anorgasmia. This is a frequent
reason for medication discontinuation. Hypertensive crisis is more characteristic of monoamine
oxidase inhibitors (MAOIs) when combined with tyramine-rich foods. Agranulocytosis and
hepatotoxicity are less common or associated with other drug classes.
,Question 6: A 70-year-old male with chronic kidney disease is given a new medication that is
primarily excreted renally. Which of the following pharmacokinetic parameters would be
most important to adjust in this patient to prevent drug toxicity?
A. Bioavailability (F)
B. Volume of distribution (Vd)
C. Half-life (t½)
D. Protein binding
CORRECT ANSWER: C. Half-life (t½)
Rationale: In renal impairment, the clearance of renally excreted drugs is reduced, leading to a
prolonged half-life (t½) and drug accumulation. Dose adjustments are typically based on the
extended half-life to maintain therapeutic levels and avoid toxicity. While volume of
distribution and protein binding can be affected by renal disease, the half-life is the primary
parameter used for dosing interval adjustments.
Question 7: A patient on warfarin therapy is prescribed amiodarone for atrial fibrillation. The
physician is concerned about a drug interaction. What is the most likely mechanism of this
interaction?
A. Displacement of warfarin from plasma protein binding sites
B. Inhibition of warfarin metabolism by CYP2C9
C. Induction of warfarin metabolism by CYP3A4
D. Additive antiplatelet effects
CORRECT ANSWER: B. Inhibition of warfarin metabolism by CYP2C9
Rationale: Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme responsible for
metabolizing the more active S-enantiomer of warfarin. This inhibition leads to increased
warfarin concentrations and a significantly elevated risk of bleeding. While amiodarone can also
interact with other pathways, CYP2C9 inhibition is the most significant mechanism.
Question 8: A 28-year-old woman with asthma is prescribed a long-acting beta-2 agonist
(LABA) as part of her maintenance therapy. Which of the following statements best describes
the recommended use of a LABA in asthma?
A. It should be used as monotherapy for mild intermittent asthma.
B. It is indicated for the acute relief of bronchospasm during an asthma attack.
C. It should always be used in combination with an inhaled corticosteroid (ICS).
D. It is the first-line treatment for exercise-induced bronchospasm.
CORRECT ANSWER: C. It should always be used in combination with an inhaled corticosteroid
(ICS).
, Rationale: LABAs (e.g., salmeterol, formoterol) are recommended for asthma management only
when used in combination with an ICS. Monotherapy with a LABA is associated with an
increased risk of asthma-related death due to masking of airway inflammation. They are not
used for acute relief (short-acting beta-2 agonists are used for that). While they can prevent
exercise-induced bronchospasm, they are not the first-line treatment for it.
Question 9: Which of the following bacterial cell wall synthesis inhibitors exerts its effect by
binding to the D-Ala-D-Ala terminal of the peptidoglycan precursor, thereby preventing
transpeptidase activity?
A. Gentamicin
B. Vancomycin
C. Ciprofloxacin
D. Erythromycin
CORRECT ANSWER: B. Vancomycin
Rationale: Vancomycin is a glycopeptide antibiotic that binds with high affinity to the D-Ala-D-
Ala terminus of the cell wall precursor unit. This prevents the transpeptidase (or penicillin-
binding proteins) from cross-linking the peptidoglycan strands, weakening the cell wall.
Gentamicin inhibits protein synthesis, ciprofloxacin inhibits DNA gyrase, and erythromycin
inhibits protein synthesis.
Question 10: A patient experiences a severe allergic reaction after receiving penicillin. The
physician decides to prescribe a macrolide antibiotic instead. Which of the following is the
primary mechanism of action of macrolides?
A. Inhibition of bacterial cell wall synthesis
B. Disruption of bacterial cell membrane function
C. Inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit
D. Inhibition of bacterial DNA replication by inhibiting DNA gyrase
CORRECT ANSWER: C. Inhibition of bacterial protein synthesis by binding to the 50S
ribosomal subunit
Rationale: Macrolides, such as erythromycin, clarithromycin, and azithromycin, are
bacteriostatic antibiotics that exert their action by reversibly binding to the 50S ribosomal
subunit, which inhibits peptide chain translocation and thus protein synthesis. They do not
affect cell wall synthesis, cell membrane, or DNA replication.
Question 11: A 60-year-old patient with benign prostatic hyperplasia (BPH) is prescribed
tamsulosin. Which of the following best describes the therapeutic effect of tamsulosin in this
condition?
A. It reduces the size of the prostate by inhibiting 5-alpha-reductase.
B. It relaxes the smooth muscle of the prostate and bladder neck to improve urine flow.
